PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30906544-0	2019	Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir.	daclatasvir	94-105	proprotein convertase subtilisin/kexin type 9	Homo sapiens	22-27	
30906544-10	2019	In summary, treatment of HCV with Daclatasvir/Asunaprevir resulted in elevated LDL, and relative miR122 and PCSK9-A levels in serum appeared to have some association with LDL increase.	daclatasvir	34-45	proprotein convertase subtilisin/kexin type 9	Homo sapiens	108-113